Enhabit, Inc. (NYSE:EHAB) CFO Ryan Solomon Buys 10,000 Shares

Key Points

• Enhabit CFO Ryan Solomon purchased 10,000 shares at an average price of $7.64, increasing his holdings by 5.45% to a total of 193,468 shares valued at approximately $1.48 million.
• Enhabit reported quarterly earnings of $0.13 per share, exceeding estimates, but analysts at UBS have lowered their price target from $10.00 to $8.50, rating the company as "neutral."
• The stock is currently trading down 4.5%, reaching $7.28, with a market capitalization of $368.38 million and a 1-year price range between $6.47 and $10.90.

Enhabit, Inc. (NYSE:EHAB - Get Free Report) CFO Ryan Solomon purchased 10,000 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were acquired at an average price of $7.64 per share, for a total transaction of $76,400.00. Following the completion of the transaction, the chief financial officer directly owned 193,468 shares of the company's stock, valued at $1,478,095.52. The trade was a 5.45% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Enhabit Trading Down 4.5%

EHAB stock traded down $0.35 during trading on Monday, reaching $7.28. 644,241 shares of the stock were exchanged, compared to its average volume of 455,639. The business has a 50 day moving average price of $8.20 and a 200-day moving average price of $8.54. Enhabit, Inc. has a 1 year low of $6.47 and a 1 year high of $10.90. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.79. The firm has a market capitalization of $368.38 million, a price-to-earnings ratio of -2.72 and a beta of 1.68.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.03. Enhabit had a positive return on equity of 2.72% and a negative net margin of 12.84%. The company had revenue of $266.10 million during the quarter, compared to analyst estimates of $263.39 million. On average, research analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Analyst Ratings Changes

Separately, UBS Group dropped their price target on Enhabit from $10.00 to $8.50 and set a "neutral" rating for the company in a research report on Friday.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC raised its stake in shares of Enhabit by 295.2% in the first quarter. GAMMA Investing LLC now owns 3,533 shares of the company's stock valued at $31,000 after acquiring an additional 2,639 shares in the last quarter. Group One Trading LLC increased its holdings in Enhabit by 248.3% during the 4th quarter. Group One Trading LLC now owns 7,746 shares of the company's stock worth $60,000 after purchasing an additional 5,522 shares during the period. Jones Financial Companies Lllp increased its holdings in Enhabit by 110,987.5% during the 1st quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company's stock worth $78,000 after purchasing an additional 8,879 shares during the period. Strs Ohio acquired a new stake in Enhabit in the 1st quarter valued at about $82,000. Finally, Quarry LP boosted its stake in shares of Enhabit by 692.6% in the 4th quarter. Quarry LP now owns 10,811 shares of the company's stock valued at $84,000 after buying an additional 9,447 shares during the period.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.